Purpose. Various syphilis screening algorithms have been proposed and are now used by many clinical laboratories following the introduction of automated treponemal tests (TTs). In France, the diagnosis of syphilis is based on a TT combined with a nontreponemal test (NTT). The objective of this study was to evaluate the diagnostic impact of NTT on initial syphilis screening at the Amiens University Hospital between January 2013 and December 2016.
INTRODUCTION
Due to the lack of in vitro culture of the causative agent of syphilis, serological tests currently constitute the first-line screening tests. Two main types of test are available: nontreponemal and treponemal tests [1, 2] . Nontreponemal tests (NTTs) are not specific and use the basic antigen formula of the Venereal Disease Research Laboratory (VDRL) test, which contains standardized amounts of cardiolipin, cholesterol and lecithin [3] . These tests detect antibodies to cardiolipin, which is a component of both the treponemal membrane and the eukaryotic mitochondrial membrane [4] . In contrast, treponemal tests (TTs) detect specific treponemal antibodies.
With the introduction of automated TTs, various screening algorithms have been proposed and are used by many clinical laboratories [5] [6] [7] . Two principal approaches are currently used. In the traditional algorithm, an NTT is used as a first-line screening test and, when it is reactive, it is followed by treponemal testing. In the second, reverse algorithm approach, which is now widely used, a TT is performed first and, when it is reactive, a NTT is then used to confirm the results and establish the state of infection. Syphilis caused by the bacterium Treponema pallidum subspecies pallidum can be classified into three infectious stages (primary, secondary and early latent) and two non-infectious disease stages (late latent and tertiary) [4] .
In France, until now, the diagnosis of syphilis has been based on a combination of TT and NTT [8] . Unlike the traditional and reverse approaches described above, according to the French strategy, the two tests are performed in parallel. The TT is now widely automated based on specific and recombinant antigens, while the NTT requires manual pipetting, which can be very time-consuming, leading to delayed results.
The present study was based on 4-year retrospective analysis of syphilis testing results. The primary objective was to estimate the added value of first-line NTTs performed in parallel with recombinant antigenic automated TTs.
METHODS

Clinical specimens
Between January 2013 and December 2016, 15 523 samples were collected for syphilis testing in Amiens University Hospital (Amiens, France). In accordance with national guidelines [8] , a TT and an NTT were performed in each case. Samples were either tested immediately or stored for approximately 24 h prior to VDRL and treponemal testing. After completion of the tests, all specimens were stored at À70
C for 1 year. 
Syphilis screening test
Statistical analysis
A nonparametric Mann-Whitney test was applied to continuous variables, and a chi-square test or Fisher's exact test was applied to categorical variables. The limit of statistical significance (two-tailed) was defined as P 0.05.
Ethics statement
A non-interventional study was performed with no additional diagnostic, monitoring or treatment procedures compared to routine patient care. Anonymized data were analysed. In accordance with French legislation on clinical trials, this type of trial did not require independent ethics committee approval or informed consent from the participants.
RESULTS
French screening algorithm and place of falsepositive results A total of 15 523 samples (received from January 2013 to December 2016) were collected for syphilis testing: 14 974 (96.5 %) samples were negative for the combined syphilis tests, and 549 (3.5 %) samples were positive for at least 1 test. Among these 549 samples, 148 (0.95 %) were reactive showed that only 4 sera exhibited reactivity with a second TPHA, which was not confirmed by line immunoassay (Fig. 1 ). For these 66 samples, the positivity of the NTT ranged from dilution 1 to 32. It should be noted that the majority of the samples (39 out of 66, 59.1 %) had a positivity of 1 and 58 samples (87.6 %) had a positivity less than or equal to 4. In this study, the confirmation tests for sera with an isolated positive NTT were negative, corresponding to a false-positive rate of 0.42 %. The lack of confirmation of positive NTTs without an associated positive TT highlights the limited value of first-line NTTs in combination with TTs. On the other hand, analysis of sera that were only positive on the automated TT chemiluminescence immunoassay (Immulite, Siemens) showed that only 52 (15.5 %) of the 335 samples were not confirmed by a second test. The number of false-positive results expressed in relation to the total number of tests performed gave a false-positive rate of 0.33 %.
Syphilis diagnosis and patient characteristics
The patient characteristics corresponding to the serum samples collected for syphilis testing between January 2013 and December 2016 are summarized in 
DISCUSSION
Although syphilis screening algorithms continue to be a subject of controversy, two serological test approaches are now commonly used: the traditional algorithm and the reverse algorithm [9] [10] [11] [12] . In contrast, according to the French strategy, the two tests are performed in parallel. The use of only one type of serological test is known to be insufficient for diagnosis, but not for screening, and can result in false-negative results in persons with primary syphilis and false-positive results in persons without syphilis. False-positive NTT results can be associated with various medical conditions and factors unrelated to syphilis, including other infections (e.g. HIV), autoimmune conditions, immunizations, pregnancy, injection drug use and older age [13] . A TT should therefore always be performed in persons with a reactive NTT in order to confirm the diagnosis of syphilis.
However, in the context of syphilis diagnosis, NTT antibody titres might correlate with disease activity and are used to follow treatment response. Results should be reported quantitatively. Nontreponemal test titres usually decline after treatment and might become nonreactive with time. However, in some people, nontreponemal antibodies can persist for a long time, corresponding to the serofast reaction. In contrast, most patients with a reactive TT maintain a reactive test for the rest of their lives, regardless of treatment or disease activity. However, 15-25 % of patients treated during the primary stage revert to being serologically nonreactive after 2-3 years. Treponemal antibody titres do not predict treatment response and therefore should not be used for this purpose [13] .
This study shows that the combined use of treponemal and nontreponemal tests for syphilis screening is ineffective, as an isolated positive NTT corresponded to a false-positive result in 0.42 % of cases, as previously described. Because NTT requires manual pipetting, which can be very time- consuming, leading to delayed results, first-line NTT performed in parallel with TT does not provide any added value. In the present study, the estimated cost of first-line NTTs for all samples was e3000 euros or about US$3500, not counting manpower. [14, 15] . Another study reported rates of 20 % for isolated reactive EIA sera for all reactive tests and 0.26 % for all tests performed [16] . Positive EIA results should always be confirmed by quantitative nontreponemal tests and treponemal tests (TPHA and/or syphilis line immunoassay) to exclude false-positives and to guide clinical management [17] .
A recrudescence of syphilis has been observed since 2000 in France and in the rest of Europe and the world [18] . The annual global incidence has been estimated by the World Health Organization (WHO) to be 12 million cases, 90 % of which are observed in developing countries [19] . In France, epidemiological surveillance was set up in 2000 to replace mandatory declarations. This study, based on a retrospective analysis of screening tests performed over a 4-year period between January 2013 and December 2016, indicates a prevalence of positive tests of 2.77 %, with a male predominance for positive screening tests corresponding to 83.1 % of cases of primary or secondary syphilis. These results are correlated with data indicating that the syphilis epidemic in Western Europe and the coastal United States predominantly concerns homosexual men [13] . The prevalence of syphilis in our hospital remains lower than that observed in other regions of France, particularly in the study conducted at Nantes University Hospital, as the percentage of two positive screening tests (TT and NTT) was 0.95 and 1.7 % for Amiens and Nantes university hospitals, respectively [20] . Similarly, the positive screening rate for one confirmed treponemal test was 1.82 and 2.7 %, respectively. This study highlights the fact that outpatient screening remains essential and predominant, but cases of positive serology are mainly observed in hospitalized patients. Due to the recrudescence of syphilis, the importance of screening, based on simpler screening algorithms, must be emphasized. French guidelines are moving in this direction. In every case, results should be interpreted in the light of the patient's characteristics.
Conclusions
In conclusion, the results of this study show that the combination of a nontreponemal test and an automated treponemal test for initial screening does not provide any diagnostic gain, but represents additional laboratory work time.
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